2016
DOI: 10.1073/pnas.1521749113
|View full text |Cite
|
Sign up to set email alerts
|

Activation of the molecular chaperone, sigma 1 receptor, preserves cone function in a murine model of inherited retinal degeneration

Abstract: Retinal degenerative diseases are major causes of untreatable blindness, and novel approaches to treatment are being sought actively. Here we explored the activation of a unique protein, sigma 1 receptor (Sig1R), in the treatment of PRC loss because of its multifaceted role in cellular survival. We used Pde6β rd10 (rd10) mice, which harbor a mutation in the rod-specific phosphodiesterase gene Pde6β and lose rod and cone photoreceptor cells (PRC) within the first 6 wk of life, as a model for severe retinal dege… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
120
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 69 publications
(125 citation statements)
references
References 58 publications
4
120
1
Order By: Relevance
“…SIGMAR1 modulates a variety of signaling pathways including ion channels, GPCRs, lipid rafts, ER stress response [14,15], as well as chromatin remodeling [16]. Studies including our own [17,18] support a protective role of SIGMAR1 in neurodegenerative diseases [19][20][21][22][23][24] and SIGMAR1 mutations are linked to familial amyotrophic lateral sclerosis (ALS) [21,25]. The crystal structure of human SIGMAR1 has been recently solved [26].…”
Section: Introductionmentioning
confidence: 99%
“…SIGMAR1 modulates a variety of signaling pathways including ion channels, GPCRs, lipid rafts, ER stress response [14,15], as well as chromatin remodeling [16]. Studies including our own [17,18] support a protective role of SIGMAR1 in neurodegenerative diseases [19][20][21][22][23][24] and SIGMAR1 mutations are linked to familial amyotrophic lateral sclerosis (ALS) [21,25]. The crystal structure of human SIGMAR1 has been recently solved [26].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, nearly 40% of all patients are afflicted by as yet unidentified genes . Notably, increasing evidence shows that, regardless of genetic defect, several common events promote the progression of retinal degeneration such as inflammation, oxidative stress, and apoptosis . Although targeting common disease mechanisms, instead of gene‐specific replacement, could not completely eliminate the detrimental effect of RP‐causing gene, it would prolong photoreceptors survival, and the impact will be enormous because photoreceptors loss in RP occurs over decades .…”
Section: Discussionmentioning
confidence: 99%
“…Although RP‐causing gene mutations, the majority of which occur in rod‐specific transcripts, initiate the photoreceptors degeneration, growing evidence indicates that several events, including neuroinflammation and apoptosis, contribute to its progression . Targeting common pathological processes holds promise for prolonging photoreceptor survival of patients late in life.…”
Section: Introductionmentioning
confidence: 99%
“…Polymerase chain reaction was performed at 95°C for 30 seconds, 63°C for 30 seconds, and 72°C for 45 seconds; melt curve analysis confirmed the purity of the end products. Resulting C Q values were normalized to Gapdh and analyzed using the comparative C Q method 31,32 to obtain fold-changes in gene expression. The analysis was performed in triplicate.…”
Section: Methodsmentioning
confidence: 99%
“…21,24,31,32 Forty to 100 μg protein was subjected to SDSPAGE at 100 V and transferred to nitrocellulose membranes at 90 V for 1.5 hours. Membranes were blocked in 5% milk in TBST (1 hour at room temperature), followed by incubation with primary antibodies: goat anti-MTHFR (Abcam, Cambridge, MA, USA; 1:500), rabbit anti-CBS (Cell Signaling, Danvers, MA, USA; 1:250), rabbit anti-CTH (Thermo-Fisher Scientific, Waltham, MA, USA; 1:500), rabbit anti-3MST (Aviva Systems Biology, San Diego, CA, USA; 1:500), rabbit anti-xCT 33 (1:800), and rabbit anti–taurine transporter (TAUT) (Alomone Labs, Jerusalem, Israel; 1:200) in 5% milk in TBST buffer at 4°C overnight.…”
Section: Methodsmentioning
confidence: 99%